Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2004
03/04/2004US20040043963 Complex of chitosan, conjugated linoleic acid, vitamin a and cyclodextrin
03/04/2004US20040043961 Transforming growth factor; antiwrinkle agent; skin disorders; using fucoidan
03/04/2004US20040043929 Novel proteins and nucleic acids encoding same
03/04/2004US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders
03/04/2004US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer
03/04/2004US20040043018 Adjust concentration of interleukins
03/04/2004US20040043007 Transfection system
03/04/2004US20040042996 Aging resistance
03/04/2004US20040042990 Composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer, and use thereof
03/04/2004US20040042978 Mixture of stannous fluoride and zinc compound
03/04/2004DE10240923A1 Flavonoid-Derivate zur Ekzem-Behandlung Flavonoid derivatives for eczema treatment
03/04/2004DE10238298A1 Verwendung von Antisense-Oligonucleotiden zur Behandlung von degenerativen Hauterscheinungen Use of antisense oligonucleotides for treatment of degenerative phenomena of skin
03/04/2004DE10238169A1 Verfahren zur vereinfachten Herstellung einer Zusammensetzung mit hohem Avarolgehalt mit verbesserter Wirkung sowie dessen Verwendung zur Behandlung proliferativer Funktionsstörungen oder zur Herstellung von reinem Avarol und Avaron hieraus A process for the simplified preparation of a composition with a high Avarolgehalt having improved activity and the use thereof for treating proliferative disorders or for preparing pure avarol and avarone thereof
03/04/2004DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical
03/04/2004CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system
03/04/2004CA2496464A1 Agent for prevention and/or treatment of itching
03/04/2004CA2495603A1 Benzonaphthyridines with pde 3/4 inhibiting activity
03/04/2004CA2495597A1 Novel phenanthridines
03/04/2004CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors
03/03/2004EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME
03/03/2004EP1393749A1 A pharmaceutical preparation in colloidal form useful in the treatment of skin diseases, comprising hyluronic acid
03/03/2004EP1393733A1 Flavonoid-derivate for the treatment of eczema
03/03/2004EP1393732A1 Minoxidil-containing liquid composition
03/03/2004EP1393633A1 Food or veterinary composition for domestic carnivores containing free tyrosine
03/03/2004EP1393075A2 Methods of screening and using inhibitors of angiogenesis
03/03/2004EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
03/03/2004EP1392852A2 Nucleic acid-associated proteins
03/03/2004EP1392844A2 Use of hmg fragments as anti-inflammatory agents
03/03/2004EP1392840A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same
03/03/2004EP1392823A2 Desaturase genes and uses thereof
03/03/2004EP1392819A2 Keratinocytes obtained from embryonic stem cells of mammals
03/03/2004EP1392694A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors
03/03/2004EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF
03/03/2004EP1392680A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
03/03/2004EP1392670A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
03/03/2004EP1392666A1 Biologically active methylene blue derivatives
03/03/2004EP1392664A1 Epothilone derivatives
03/03/2004EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
03/03/2004EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents
03/03/2004EP1392655A2 Potassium channel openers
03/03/2004EP1392651A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
03/03/2004EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
03/03/2004EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives
03/03/2004EP1392623A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms
03/03/2004EP1392398A2 Cosmetic and dermatological preparations for removing and regulating sebum
03/03/2004EP1392369A2 Use of sheets for producing body compresses and a pre-product and device therefor
03/03/2004EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
03/03/2004EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs
03/03/2004EP1392354A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
03/03/2004EP1392351A2 Chemokines as adjuvants of immune response
03/03/2004EP1392349A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
03/03/2004EP1392335A1 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
03/03/2004EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
03/03/2004EP1392317A2 Substituted 1-benzazepines and derivatives thereof
03/03/2004EP1392311A1 Pyrimidine derivatives as selective inhibitors of cox-2
03/03/2004EP1392309A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
03/03/2004EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
03/03/2004EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
03/03/2004EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
03/03/2004EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
03/03/2004EP1392289A2 Caspase inhibitors and uses thereof
03/03/2004EP1392282A2 Dermatological and cosmetic compositions
03/03/2004EP1392278A1 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
03/03/2004EP1392276A1 Potentiation of therapeutic effects of polyunsaturated fatty acids
03/03/2004EP1392272A1 Permeation enhancers
03/03/2004EP1392131A2 Skin diet
03/03/2004EP1392116A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
03/03/2004EP1244464B1 Extract of dedifferentiated cells from a plant belonging to the genus leontopodium and compositions containing same
03/03/2004EP1196440B1 Therapeutic peptides derived from subsequences of bpi
03/03/2004EP1087780B1 Extraction method of a compound from vegetable material
03/03/2004EP1047437A4 Sea cucumber carotenoid lipid fraction products and methods of use
03/03/2004EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy
03/03/2004EP1032364B1 Topical compositions containing sialyl sugars and their derivatives
03/03/2004EP0998460B1 Novel tetrazole derivatives
03/03/2004EP0986386B1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
03/03/2004EP0934053B1 Cosmetic or dermatological microemulsions
03/03/2004EP0923366B1 Sunscreen compositions containing damaged rna fragments
03/03/2004EP0831850B1 Use of locally applied dna fragments
03/03/2004EP0719150B1 Cellular vaccine and its use for the treatment of solid tumor malignancies
03/03/2004CN1479749A Polysaccharide compound having immune stimulating activity
03/03/2004CN1479740A Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines
03/03/2004CN1479739A Heterocyclic ether substituted imidazoquinolie compounds
03/03/2004CN1479738A Thioether subsituted imidazoquinoline compound
03/03/2004CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes
03/03/2004CN1479637A Composition and using method
03/03/2004CN1479629A Combinations and compositions which interfere with VEGF/VEFG and anglopoietin/Tie receptor function and their use (II)
03/03/2004CN1479625A Herbal pharmaceutical compositions for treating immun logical disorders
03/03/2004CN1479624A Process for preparing aqueous extracts of plants and extracts so obtained
03/03/2004CN1478547A Collagen protein health protection capsule
03/03/2004CN1478529A Phellodemdron bark-nine Chinese medicinal material and inhaler for treating acute, ssubacute cutitis
03/03/2004CN1478518A Medicine for treating lupus erythematosus, dermatomyositis, dermatos clerosis and sicca syndrome
03/03/2004CN1478514A Chinese medicine for treating burn, scald and waund
03/03/2004CN1478513A Medicinal powder for treating burn and scald
03/03/2004CN1478512A Chinese Medicine for treating ulcerated venereal disease
03/03/2004CN1478496A Method and technology of preparing special effect ointment for eliminating chorioplaque
03/03/2004CN1478493A Medicine yimoqing for treating scald
03/03/2004CN1478491A Compound aloe cream for eliminating pox and cicatrice
03/03/2004CN1478490A Medicinal liquid for treating skin ulceration and stonatocace and its processing technology
03/03/2004CN1478485A Liposome ointment containing heparin kind medicine and its preparation method
03/03/2004CN1478478A Medicinal composition for treating psoriasis